PRUITT MICHAEL D (CEO, Chairman) purchased 19.3% of their position (5K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $3.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/19/2019ACC: 0001493152-19-012976
DirectorOfficer· CEO, Chairman
Since Aug 2018
+5K
Net shares
Net buyer
$3.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+5K
Price / share
$0.61
Trade value
$3.05K
% of position
19.3%
8/19/2019
25.96K→30.96K
Total
Net shares
+5K
Net value
$3.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/19/2019 | P · Purchase | +5K | $0.61 | $3.05K | 19.3% | 25.96K | 30.96K |
| Total | +5K | $3.05K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
DirectShares owned17.26K
Common Stock
IndirectShares owned3.36K
Series 1 Preferred Stock
IndirectShares owned330.00
Total
17.26K direct·3.69K indirect20.94K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 17.26K | Direct |
| Common Stock | 3.36K | Indirect |
| Series 1 Preferred Stock | 330.00 | Indirect |
| Total | 20.94K | 17.26K direct·3.69K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported